nodes	percent_of_prediction	percent_of_DWPC	metapath
Amisulpride—HTR7—sympathetic nervous system—adrenal gland cancer	0.137	0.231	CbGeAlD
Amisulpride—HTR7—vein—adrenal gland cancer	0.129	0.216	CbGeAlD
Amisulpride—HTR2A—sympathetic nervous system—adrenal gland cancer	0.0856	0.144	CbGeAlD
Amisulpride—HTR2A—vein—adrenal gland cancer	0.0801	0.135	CbGeAlD
Amisulpride—HTR2A—urine—adrenal gland cancer	0.0469	0.079	CbGeAlD
Amisulpride—HTR2B—adrenal cortex—adrenal gland cancer	0.0233	0.0392	CbGeAlD
Amisulpride—HTR2B—adrenal gland—adrenal gland cancer	0.0168	0.0283	CbGeAlD
Amisulpride—HTR7—gonad—adrenal gland cancer	0.0165	0.0278	CbGeAlD
Amisulpride—HTR7—Serotonin Receptor 4/6/7 and NR3C Signaling—GNAS—adrenal gland cancer	0.0161	0.0396	CbGpPWpGaD
Amisulpride—DRD3—Nicotine Activity on Dopaminergic Neurons—PRKACA—adrenal gland cancer	0.0156	0.0384	CbGpPWpGaD
Amisulpride—DRD2—pituitary gland—adrenal gland cancer	0.0152	0.0256	CbGeAlD
Amisulpride—HTR7—Circadian rythm related genes—SFPQ—adrenal gland cancer	0.0149	0.0368	CbGpPWpGaD
Amisulpride—HTR7—GPCRs, Other—GNRHR—adrenal gland cancer	0.0148	0.0364	CbGpPWpGaD
Amisulpride—HTR7—adrenal gland—adrenal gland cancer	0.0144	0.0242	CbGeAlD
Amisulpride—DRD3—Circadian rythm related genes—SFPQ—adrenal gland cancer	0.0127	0.0313	CbGpPWpGaD
Amisulpride—DRD3—GPCRs, Other—GNRHR—adrenal gland cancer	0.0126	0.031	CbGpPWpGaD
Amisulpride—DRD2—Nicotine Activity on Dopaminergic Neurons—PRKACA—adrenal gland cancer	0.0119	0.0294	CbGpPWpGaD
Amisulpride—HTR7—Serotonin Receptor 4/6/7 and NR3C Signaling—BRAF—adrenal gland cancer	0.0107	0.0264	CbGpPWpGaD
Amisulpride—HTR2A—gonad—adrenal gland cancer	0.0103	0.0173	CbGeAlD
Amisulpride—HTR2A—pituitary gland—adrenal gland cancer	0.01	0.0169	CbGeAlD
Amisulpride—DRD2—Circadian rythm related genes—SFPQ—adrenal gland cancer	0.00972	0.0239	CbGpPWpGaD
Amisulpride—HTR2A—GPCRs, Other—GNRHR—adrenal gland cancer	0.00947	0.0233	CbGpPWpGaD
Amisulpride—HTR2A—adrenal gland—adrenal gland cancer	0.00897	0.0151	CbGeAlD
Amisulpride—DRD2—Hypothetical Network for Drug Addiction—PRKACA—adrenal gland cancer	0.00851	0.021	CbGpPWpGaD
Amisulpride—HTR2B—G alpha (q) signalling events—GNRHR—adrenal gland cancer	0.0076	0.0187	CbGpPWpGaD
Amisulpride—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—GNRHR—adrenal gland cancer	0.0068	0.0167	CbGpPWpGaD
Amisulpride—HTR7—G alpha (s) signalling events—TSHR—adrenal gland cancer	0.00617	0.0152	CbGpPWpGaD
Amisulpride—HTR7—Class A/1 (Rhodopsin-like receptors)—GNRHR—adrenal gland cancer	0.00551	0.0136	CbGpPWpGaD
Amisulpride—HTR2A—G alpha (q) signalling events—GNRHR—adrenal gland cancer	0.00532	0.0131	CbGpPWpGaD
Amisulpride—HTR2B—Class A/1 (Rhodopsin-like receptors)—GNRHR—adrenal gland cancer	0.00503	0.0124	CbGpPWpGaD
Amisulpride—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—GNRHR—adrenal gland cancer	0.00476	0.0117	CbGpPWpGaD
Amisulpride—DRD3—Class A/1 (Rhodopsin-like receptors)—GNRHR—adrenal gland cancer	0.00468	0.0115	CbGpPWpGaD
Amisulpride—HTR2B—G alpha (q) signalling events—GNRH1—adrenal gland cancer	0.00455	0.0112	CbGpPWpGaD
Amisulpride—HTR7—GPCR ligand binding—GNRHR—adrenal gland cancer	0.00419	0.0103	CbGpPWpGaD
Amisulpride—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—GNRH1—adrenal gland cancer	0.00407	0.01	CbGpPWpGaD
Amisulpride—HTR2B—GPCR ligand binding—GNRHR—adrenal gland cancer	0.00383	0.00944	CbGpPWpGaD
Amisulpride—HTR7—G alpha (s) signalling events—GNAS—adrenal gland cancer	0.00359	0.00884	CbGpPWpGaD
Amisulpride—DRD2—Class A/1 (Rhodopsin-like receptors)—GNRHR—adrenal gland cancer	0.00358	0.00883	CbGpPWpGaD
Amisulpride—DRD3—GPCR ligand binding—GNRHR—adrenal gland cancer	0.00357	0.00878	CbGpPWpGaD
Amisulpride—HTR2A—Class A/1 (Rhodopsin-like receptors)—GNRHR—adrenal gland cancer	0.00353	0.00868	CbGpPWpGaD
Amisulpride—HTR7—Circadian rythm related genes—TOP2A—adrenal gland cancer	0.00342	0.00842	CbGpPWpGaD
Amisulpride—HTR7—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.0033	0.00813	CbGpPWpGaD
Amisulpride—HTR2A—G alpha (q) signalling events—GNRH1—adrenal gland cancer	0.00319	0.00786	CbGpPWpGaD
Amisulpride—HTR2B—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.00302	0.00743	CbGpPWpGaD
Amisulpride—HTR7—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.00294	0.00724	CbGpPWpGaD
Amisulpride—DRD3—Circadian rythm related genes—TOP2A—adrenal gland cancer	0.00291	0.00716	CbGpPWpGaD
Amisulpride—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—GNRH1—adrenal gland cancer	0.00285	0.00703	CbGpPWpGaD
Amisulpride—DRD3—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.00281	0.00691	CbGpPWpGaD
Amisulpride—DRD2—GPCR ligand binding—GNRHR—adrenal gland cancer	0.00273	0.00672	CbGpPWpGaD
Amisulpride—HTR2B—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.00269	0.00662	CbGpPWpGaD
Amisulpride—HTR2A—GPCR ligand binding—GNRHR—adrenal gland cancer	0.00269	0.00661	CbGpPWpGaD
Amisulpride—HTR7—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00251	0.00619	CbGpPWpGaD
Amisulpride—DRD3—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.0025	0.00616	CbGpPWpGaD
Amisulpride—HTR7—G alpha (s) signalling events—POMC—adrenal gland cancer	0.00242	0.00595	CbGpPWpGaD
Amisulpride—HTR7—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00237	0.00584	CbGpPWpGaD
Amisulpride—HTR2A—SIDS Susceptibility Pathways—PRKACA—adrenal gland cancer	0.00236	0.00581	CbGpPWpGaD
Amisulpride—HTR2B—GPCR ligand binding—GNRH1—adrenal gland cancer	0.0023	0.00566	CbGpPWpGaD
Amisulpride—HTR7—GPCR ligand binding—TSHR—adrenal gland cancer	0.00224	0.00552	CbGpPWpGaD
Amisulpride—DRD2—Circadian rythm related genes—TOP2A—adrenal gland cancer	0.00222	0.00548	CbGpPWpGaD
Amisulpride—HTR2B—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00217	0.00533	CbGpPWpGaD
Amisulpride—HTR7—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00215	0.0053	CbGpPWpGaD
Amisulpride—DRD2—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.00215	0.00529	CbGpPWpGaD
Amisulpride—DRD3—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00214	0.00526	CbGpPWpGaD
Amisulpride—HTR2A—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.00211	0.0052	CbGpPWpGaD
Amisulpride—HTR2B—GPCR ligand binding—TSHR—adrenal gland cancer	0.00205	0.00504	CbGpPWpGaD
Amisulpride—DRD3—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00202	0.00496	CbGpPWpGaD
Amisulpride—HTR2B—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00197	0.00484	CbGpPWpGaD
Amisulpride—DRD2—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.00191	0.00471	CbGpPWpGaD
Amisulpride—DRD3—GPCR ligand binding—TSHR—adrenal gland cancer	0.0019	0.00469	CbGpPWpGaD
Amisulpride—HTR2A—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.00188	0.00464	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00183	0.00451	CbGpPWpGaD
Amisulpride—DRD3—G alpha (i) signalling events—GNAS—adrenal gland cancer	0.00183	0.00451	CbGpPWpGaD
Amisulpride—DRD2—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00163	0.00403	CbGpPWpGaD
Amisulpride—HTR2A—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00161	0.00396	CbGpPWpGaD
Amisulpride—DRD2—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00154	0.0038	CbGpPWpGaD
Amisulpride—HTR2A—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00152	0.00374	CbGpPWpGaD
Amisulpride—DRD2—GPCR ligand binding—TSHR—adrenal gland cancer	0.00146	0.00359	CbGpPWpGaD
Amisulpride—HTR2A—GPCR ligand binding—TSHR—adrenal gland cancer	0.00143	0.00353	CbGpPWpGaD
Amisulpride—HTR7—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00142	0.0035	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—GNRHR—adrenal gland cancer	0.0014	0.00345	CbGpPWpGaD
Amisulpride—DRD2—G alpha (i) signalling events—GNAS—adrenal gland cancer	0.0014	0.00345	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00138	0.00339	CbGpPWpGaD
Amisulpride—HTR7—GPCR ligand binding—GNAS—adrenal gland cancer	0.0013	0.00321	CbGpPWpGaD
Amisulpride—HTR2B—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.0013	0.0032	CbGpPWpGaD
Amisulpride—HTR7—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00129	0.00318	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—GNRHR—adrenal gland cancer	0.00127	0.00313	CbGpPWpGaD
Amisulpride—HTR7—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00127	0.00312	CbGpPWpGaD
Amisulpride—DRD3—G alpha (i) signalling events—POMC—adrenal gland cancer	0.00123	0.00303	CbGpPWpGaD
Amisulpride—DRD3—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00121	0.00297	CbGpPWpGaD
Amisulpride—HTR2B—GPCR ligand binding—GNAS—adrenal gland cancer	0.00119	0.00293	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00118	0.00291	CbGpPWpGaD
Amisulpride—HTR2B—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00118	0.0029	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—GNRHR—adrenal gland cancer	0.00116	0.00286	CbGpPWpGaD
Amisulpride—HTR2B—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00116	0.00285	CbGpPWpGaD
Amisulpride—HTR7—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00115	0.00284	CbGpPWpGaD
Amisulpride—HTR7—Signaling by GPCR—TSHR—adrenal gland cancer	0.00115	0.00283	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00111	0.00274	CbGpPWpGaD
Amisulpride—DRD3—GPCR ligand binding—GNAS—adrenal gland cancer	0.00111	0.00273	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—GNRH1—adrenal gland cancer	0.0011	0.0027	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—GNRHR—adrenal gland cancer	0.00108	0.00266	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00108	0.00266	CbGpPWpGaD
Amisulpride—DRD3—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00108	0.00265	CbGpPWpGaD
Amisulpride—HTR2B—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00105	0.00259	CbGpPWpGaD
Amisulpride—HTR2B—Signaling by GPCR—TSHR—adrenal gland cancer	0.00105	0.00259	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00102	0.0025	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00101	0.00248	CbGpPWpGaD
Amisulpride—DRD3—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.000979	0.00241	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—TSHR—adrenal gland cancer	0.000977	0.00241	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—ZNRF3—adrenal gland cancer	0.000945	0.00233	CbGpPWpGaD
Amisulpride—DRD2—G alpha (i) signalling events—POMC—adrenal gland cancer	0.000943	0.00232	CbGpPWpGaD
Amisulpride—DRD2—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.000924	0.00228	CbGpPWpGaD
Amisulpride—HTR2A—SIDS Susceptibility Pathways—CTNNB1—adrenal gland cancer	0.000919	0.00226	CbGpPWpGaD
Amisulpride—HTR2A—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.000909	0.00224	CbGpPWpGaD
Amisulpride—HTR7—GPCR ligand binding—POMC—adrenal gland cancer	0.000877	0.00216	CbGpPWpGaD
Amisulpride—DRD2—GPCR ligand binding—GNAS—adrenal gland cancer	0.000848	0.00209	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—GNRH1—adrenal gland cancer	0.000839	0.00207	CbGpPWpGaD
Amisulpride—HTR2A—GPCR ligand binding—GNAS—adrenal gland cancer	0.000834	0.00205	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—GNRHR—adrenal gland cancer	0.000827	0.00204	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—GNRH1—adrenal gland cancer	0.000825	0.00203	CbGpPWpGaD
Amisulpride—HTR7—Signaling by GPCR—PRKACA—adrenal gland cancer	0.000825	0.00203	CbGpPWpGaD
Amisulpride—DRD2—GPCR downstream signaling—TSHR—adrenal gland cancer	0.000823	0.00203	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—GNRHR—adrenal gland cancer	0.000814	0.002	CbGpPWpGaD
Amisulpride—HTR2A—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00081	0.002	CbGpPWpGaD
Amisulpride—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	0.000804	0.00198	CbGpPWpGaD
Amisulpride—HTR2B—GPCR ligand binding—POMC—adrenal gland cancer	0.000802	0.00197	CbGpPWpGaD
Amisulpride—HTR7—Circadian rythm related genes—TP53—adrenal gland cancer	0.000779	0.00192	CbGpPWpGaD
Amisulpride—HTR7—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00077	0.0019	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.000769	0.00189	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—GNRH1—adrenal gland cancer	0.000762	0.00188	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.000757	0.00186	CbGpPWpGaD
Amisulpride—HTR2B—Signaling by GPCR—PRKACA—adrenal gland cancer	0.000754	0.00186	CbGpPWpGaD
Amisulpride—DRD2—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.000749	0.00185	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—TSHR—adrenal gland cancer	0.000748	0.00184	CbGpPWpGaD
Amisulpride—DRD3—GPCR ligand binding—POMC—adrenal gland cancer	0.000746	0.00184	CbGpPWpGaD
Amisulpride—HTR2A—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.000737	0.00182	CbGpPWpGaD
Amisulpride—HTR7—GPCR downstream signaling—GNAS—adrenal gland cancer	0.000736	0.00181	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—TSHR—adrenal gland cancer	0.000736	0.00181	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—ZNRF3—adrenal gland cancer	0.000723	0.00178	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—ZNRF3—adrenal gland cancer	0.000711	0.00175	CbGpPWpGaD
Amisulpride—HTR2B—GPCR downstream signaling—CDC42—adrenal gland cancer	0.000704	0.00173	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—PRKACA—adrenal gland cancer	0.000701	0.00173	CbGpPWpGaD
Amisulpride—HTR7—Signaling by GPCR—CDC42—adrenal gland cancer	0.0007	0.00172	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—SPRY2—adrenal gland cancer	0.000697	0.00172	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—GNRH1—adrenal gland cancer	0.000696	0.00171	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—TSHR—adrenal gland cancer	0.000679	0.00167	CbGpPWpGaD
Amisulpride—HTR2B—GPCR downstream signaling—GNAS—adrenal gland cancer	0.000673	0.00166	CbGpPWpGaD
Amisulpride—HTR7—Signaling by GPCR—GNAS—adrenal gland cancer	0.000669	0.00165	CbGpPWpGaD
Amisulpride—DRD3—Circadian rythm related genes—TP53—adrenal gland cancer	0.000663	0.00163	CbGpPWpGaD
Amisulpride—DRD3—GPCR downstream signaling—CDC42—adrenal gland cancer	0.000655	0.00161	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—GNRH1—adrenal gland cancer	0.000648	0.0016	CbGpPWpGaD
Amisulpride—HTR2B—Signaling by GPCR—CDC42—adrenal gland cancer	0.000639	0.00157	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—MEN1—adrenal gland cancer	0.000638	0.00157	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—SPRY2—adrenal gland cancer	0.000637	0.00157	CbGpPWpGaD
Amisulpride—DRD3—GPCR downstream signaling—GNAS—adrenal gland cancer	0.000626	0.00154	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—TSHR—adrenal gland cancer	0.00062	0.00153	CbGpPWpGaD
Amisulpride—HTR2B—Signaling by GPCR—GNAS—adrenal gland cancer	0.000611	0.0015	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—CDC42—adrenal gland cancer	0.000595	0.00147	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—SPRY2—adrenal gland cancer	0.000592	0.00146	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—MEN1—adrenal gland cancer	0.000583	0.00144	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—TSHR—adrenal gland cancer	0.000577	0.00142	CbGpPWpGaD
Amisulpride—DRD2—GPCR ligand binding—POMC—adrenal gland cancer	0.000571	0.00141	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—GNAS—adrenal gland cancer	0.000568	0.0014	CbGpPWpGaD
Amisulpride—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	0.000563	0.00139	CbGpPWpGaD
Amisulpride—HTR2A—GPCR ligand binding—POMC—adrenal gland cancer	0.000562	0.00138	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—MEN1—adrenal gland cancer	0.000543	0.00134	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—PRKACA—adrenal gland cancer	0.000537	0.00132	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—PRKACA—adrenal gland cancer	0.000528	0.0013	CbGpPWpGaD
Amisulpride—DRD2—Circadian rythm related genes—TP53—adrenal gland cancer	0.000507	0.00125	CbGpPWpGaD
Amisulpride—DRD2—GPCR downstream signaling—CDC42—adrenal gland cancer	0.000501	0.00123	CbGpPWpGaD
Amisulpride—HTR7—GPCR downstream signaling—POMC—adrenal gland cancer	0.000496	0.00122	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—GNRH1—adrenal gland cancer	0.000496	0.00122	CbGpPWpGaD
Amisulpride—HTR2A—GPCR downstream signaling—CDC42—adrenal gland cancer	0.000493	0.00121	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—GNRH1—adrenal gland cancer	0.000488	0.0012	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—PRKACA—adrenal gland cancer	0.000487	0.0012	CbGpPWpGaD
Amisulpride—DRD2—GPCR downstream signaling—GNAS—adrenal gland cancer	0.000479	0.00118	CbGpPWpGaD
Amisulpride—HTR2A—GPCR downstream signaling—GNAS—adrenal gland cancer	0.000471	0.00116	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—CDC42—adrenal gland cancer	0.000455	0.00112	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—SPRY2—adrenal gland cancer	0.000453	0.00112	CbGpPWpGaD
Amisulpride—HTR2B—GPCR downstream signaling—POMC—adrenal gland cancer	0.000453	0.00112	CbGpPWpGaD
Amisulpride—HTR7—Signaling by GPCR—POMC—adrenal gland cancer	0.00045	0.00111	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—CDC42—adrenal gland cancer	0.000448	0.0011	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—SPRY2—adrenal gland cancer	0.000446	0.0011	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—PRKACA—adrenal gland cancer	0.000445	0.0011	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—TSHR—adrenal gland cancer	0.000442	0.00109	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—GNAS—adrenal gland cancer	0.000435	0.00107	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—TSHR—adrenal gland cancer	0.000435	0.00107	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—GNAS—adrenal gland cancer	0.000428	0.00105	CbGpPWpGaD
Amisulpride—DRD3—GPCR downstream signaling—POMC—adrenal gland cancer	0.000421	0.00104	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—MEN1—adrenal gland cancer	0.000415	0.00102	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—PRKACA—adrenal gland cancer	0.000414	0.00102	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—CDC42—adrenal gland cancer	0.000413	0.00102	CbGpPWpGaD
Amisulpride—HTR2B—Signaling by GPCR—POMC—adrenal gland cancer	0.000411	0.00101	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—MEN1—adrenal gland cancer	0.000409	0.00101	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—IGF2—adrenal gland cancer	0.000398	0.000981	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—GNAS—adrenal gland cancer	0.000395	0.000973	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—IGF1R—adrenal gland cancer	0.000385	0.000949	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—POMC—adrenal gland cancer	0.000383	0.000943	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—CDC42—adrenal gland cancer	0.000378	0.00093	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—IGF2—adrenal gland cancer	0.000364	0.000897	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—GNAS—adrenal gland cancer	0.000361	0.000889	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—IGF1R—adrenal gland cancer	0.000352	0.000867	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—CDC42—adrenal gland cancer	0.000351	0.000866	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—IGF2—adrenal gland cancer	0.000339	0.000834	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—GNAS—adrenal gland cancer	0.000336	0.000827	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—TERT—adrenal gland cancer	0.000332	0.000817	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—IGF1R—adrenal gland cancer	0.000327	0.000807	CbGpPWpGaD
Amisulpride—DRD2—GPCR downstream signaling—POMC—adrenal gland cancer	0.000323	0.000794	CbGpPWpGaD
Amisulpride—HTR2A—GPCR downstream signaling—POMC—adrenal gland cancer	0.000317	0.000782	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—PRKACA—adrenal gland cancer	0.000317	0.000781	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—PRKACA—adrenal gland cancer	0.000312	0.000768	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—TERT—adrenal gland cancer	0.000303	0.000746	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—POMC—adrenal gland cancer	0.000293	0.000721	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—BAD—adrenal gland cancer	0.000288	0.00071	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—POMC—adrenal gland cancer	0.000288	0.00071	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—TERT—adrenal gland cancer	0.000282	0.000694	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—CDC42—adrenal gland cancer	0.000269	0.000662	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—POMC—adrenal gland cancer	0.000266	0.000655	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—CDC42—adrenal gland cancer	0.000265	0.000652	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—BAD—adrenal gland cancer	0.000264	0.000649	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—BRAF—adrenal gland cancer	0.000263	0.000647	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—IGF2—adrenal gland cancer	0.000259	0.000638	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—GNAS—adrenal gland cancer	0.000257	0.000633	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—IGF2—adrenal gland cancer	0.000255	0.000628	CbGpPWpGaD
Amisulpride—HTR7—Signaling by GPCR—EGFR—adrenal gland cancer	0.000255	0.000627	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—GNAS—adrenal gland cancer	0.000253	0.000623	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—IGF1R—adrenal gland cancer	0.000251	0.000617	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—IGF1R—adrenal gland cancer	0.000247	0.000607	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—BAD—adrenal gland cancer	0.000245	0.000604	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—POMC—adrenal gland cancer	0.000243	0.000598	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—BRAF—adrenal gland cancer	0.00024	0.000591	CbGpPWpGaD
Amisulpride—HTR2B—Signaling by GPCR—EGFR—adrenal gland cancer	0.000233	0.000573	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—POMC—adrenal gland cancer	0.000226	0.000557	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—BRAF—adrenal gland cancer	0.000223	0.00055	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—EGFR—adrenal gland cancer	0.000216	0.000533	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—TERT—adrenal gland cancer	0.000216	0.000531	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—TERT—adrenal gland cancer	0.000212	0.000523	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—CTNNB1—adrenal gland cancer	0.00019	0.000467	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—BAD—adrenal gland cancer	0.000188	0.000462	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—BAD—adrenal gland cancer	0.000185	0.000455	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000173	0.000427	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—POMC—adrenal gland cancer	0.000173	0.000426	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—BRAF—adrenal gland cancer	0.000171	0.000421	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—POMC—adrenal gland cancer	0.00017	0.000419	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—BRAF—adrenal gland cancer	0.000168	0.000414	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—EGFR—adrenal gland cancer	0.000166	0.000408	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—EGFR—adrenal gland cancer	0.000163	0.000401	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000161	0.000397	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—EGFR—adrenal gland cancer	0.00015	0.00037	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—EGFR—adrenal gland cancer	0.000137	0.000338	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—EGFR—adrenal gland cancer	0.000128	0.000315	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—TP53—adrenal gland cancer	0.000126	0.000311	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000123	0.000304	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000121	0.000299	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—TP53—adrenal gland cancer	0.000115	0.000284	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—TP53—adrenal gland cancer	0.000107	0.000264	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—EGFR—adrenal gland cancer	9.78e-05	0.000241	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—EGFR—adrenal gland cancer	9.62e-05	0.000237	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—TP53—adrenal gland cancer	8.21e-05	0.000202	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—TP53—adrenal gland cancer	8.08e-05	0.000199	CbGpPWpGaD
